Galaxy Surfact.

Who are the top shareholders of the Galaxy Surfact.?

The top shareholders of Galaxy Surfact include promoters holding the majority, with Unnathan Shekhar at 11.92%. Institutional investors, including mutual funds at 11.57% and foreign institutional investors at 4.09%, along with individual investors at 8.64%, also contribute to the shareholding.

The top shareholders of Galaxy Surfact include the promoters, who hold the majority of the shares. Unnathan Shekhar is the promoter with the highest holding at 11.92%. In terms of institutional investors, mutual funds collectively hold 11.57% across six schemes, with Axis Mutual Fund being the highest public shareholder at 4.38%. Additionally, foreign institutional investors (FIIs) hold 4.09%, while individual investors account for 8.64% of the shareholding. The pledged promoter holdings are quite low at 0.0166%.

Who are in the management team of Galaxy Surfact.?

As of March 2023, the management team of Galaxy Surfact includes Shekhar Unnathan (Managing Director), Melarkode Ganesan Parameswaran (Chairman), and several other directors and officers, totaling 11 members with diverse expertise.

As of March 2023, the management team of Galaxy Surfact includes the following individuals:<BR><BR>1. **Subodh Satchitanand Nadkarni** - Non-Executive & Independent Director<BR>2. **Ramakrishnan Gopalkrishnan** - Non-Executive & Non-Independent Director<BR>3. **Shekhar Unnathan** - Managing Director<BR>4. **Melarkode Ganesan Parameswaran** - Chairman & Independent Director<BR>5. **Nandita Mohan Gurjar** - Non-Executive & Independent Director<BR>6. **Natarajan K Krishnan** - Executive Director & COO<BR>7. **Vaijanath Kulkarni** - Whole-time Director<BR>8. **Shashikant Rayappa Shanbhag** - Non-Executive & Non-Independent Director<BR>9. **K B S Anand** - Independent Director<BR>10. **Shipra Rathi** - Company Secretary & Compliance Officer<BR>11. **Hariharan Madhavan** - Independent Director<BR><BR>This diverse team brings a range of expertise and leadership to the company.

Has Galaxy Surfact. declared dividend?

Yes, Galaxy Surfactants Ltd has declared a dividend of 180% (₹18 per share) with an ex-date of March 20, 2025. While recent total returns have been negative, the company has shown strong growth over the past five years with an overall return of 82.89%.

Galaxy Surfactants Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 180%<BR>- Amount per share: 18 per share<BR>- Ex-date: 20 Mar 25<BR><BR>Dividend Yield: 1.68%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -16.91%, the dividend return was 0.64%, resulting in a total return of -16.27%.<BR><BR>Over the past year, the price return was -7.25%, the dividend return was 1.50%, leading to a total return of -5.75%.<BR><BR>In the 2-year period, the price return was -9.2%, the dividend return was 1.55%, which resulted in a total return of -7.65%.<BR><BR>For the last 3 years, the price return was -18.07%, the dividend return was 2.73%, culminating in a total return of -15.34%.<BR><BR>In the 4-year period, the price return was -19.98%, the dividend return was 2.77%, resulting in a total return of -17.21%.<BR><BR>Over the last 5 years, the price return was 76.58%, the dividend return was 6.31%, leading to a total return of 82.89%.<BR><BR>Overall, Galaxy Surfactants Ltd has declared a significant dividend, but the total returns over shorter periods have been negative, indicating challenges in price performance. However, the long-term return over five years shows a strong recovery, highlighting potential for future growth.

Who are the peers of the Galaxy Surfact.?

Peers of Galaxy Surfact. include Pidilite Inds., SRF, Gujarat Fluoroch, and others. Galaxy Surfact. has a Below Average growth rate and a 1-year return of -5.52%, higher than Deepak Nitrite but lower than SRF's 30.74%.

Peers: The peers of Galaxy Surfact. are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Elantas Beck, Epigral, Archean Chemical, Laxmi Organic, and Styrenix Perfor.<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite, while Good management risk is found at Pidilite Inds., SRF, Galaxy Surfact., Elantas Beck, Epigral, Archean Chemical, and the rest. Average management risk is noted at Gujarat Fluoroch and Himadri Special, while Laxmi Organic has Average management risk. Growth is Average at Pidilite Inds. and SRF, while Below Average growth is seen at Galaxy Surfact., Elantas Beck, Epigral, Gujarat Fluoroch, Deepak Nitrite, and the rest. Good growth is observed at Himadri Special, while Laxmi Organic has Below Average growth. Capital Structure is Excellent at Pidilite Inds., SRF, Deepak Nitrite, Galaxy Surfact., Elantas Beck, Archean Chemical, and the rest, while Good capital structure is found at Gujarat Fluoroch and Himadri Special, and Average at Laxmi Organic.<BR><BR>Return Snapshot: The peer with the highest 1-year return is SRF at 30.74%, while the lowest is Deepak Nitrite at -9.57%. Galaxy Surfact.'s 1-year return is -5.52%, which is higher than Deepak Nitrite's but lower than SRF's. Additionally, peers with negative six-month returns include Deepak Nitrite, Elantas Beck, and Laxmi Organic.

What does Galaxy Surfact. do?

Galaxy Surfactants Ltd is a mid-cap company in the specialty chemicals industry, reporting net sales of ₹11,449 Cr and a net profit of ₹759 Cr for March 2025. Key metrics include a P/E ratio of 30.00, a dividend yield of 1.54%, and a market cap of ₹9,250 Cr.

Overview: <BR>Galaxy Surfactants Ltd operates in the specialty chemicals industry and is categorized as a mid-cap company.<BR><BR>History: <BR>The company was originally incorporated as 'Galaxy Surfactants Private Limited' in 1986 and later converted to a public limited company, changing its name to 'Galaxy Surfactants Limited' in 1995. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 11,449 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 759 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 9,250 Cr (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: 30.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 1.54% <BR>Debt Equity: -0.13 <BR>Return on Equity: 12.91% <BR>Price to Book: 3.91<BR><BR>Contact Details: <BR>Address: C-49/2 TTC Industrial Area, Pawne Navi Mumbai Maharashtra : 400703 <BR>Tel: 91-22-65134444/27616666 <BR>Email: galaxy@galaxysurfactants.com <BR>Website: http://www.galaxysurfactants.com

How big is Galaxy Surfact.?

As of 24th July, Galaxy Surfactants Ltd has a market capitalization of 9,179.00 Cr, with recent net sales of 4,223.67 Cr and a net profit of 304.91 Cr.

As of 24th July, <BR><BR>Market Cap: Galaxy Surfactants Ltd has a market capitalization of 9,179.00 Cr and is classified as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported Net Sales of 4,223.67 Cr and a Net Profit of 304.91 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025, with Shareholder's Funds amounting to 2,362.54 Cr and Total Assets of 3,449.99 Cr.

Is Galaxy Surfact. technically bullish or bearish?

As of November 6, 2025, the technical trend for Galaxy Surfact has shifted to a bearish outlook, supported by bearish signals from the MACD, KST, and moving averages, despite a bullish weekly RSI.

As of 6 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish, with a moderate strength indicated by the weekly MACD and KST both showing bearish signals. The daily moving averages also confirm a bearish outlook. While the weekly RSI is bullish, it is not enough to counter the overall bearish sentiment from the other indicators. Bollinger Bands and OBV are both mildly bearish on the weekly timeframe, further supporting the bearish stance. Overall, the combination of these indicators suggests a bearish outlook for Galaxy Surfact.

How has been the historical performance of Galaxy Surfact.?

Galaxy Surfact's historical performance shows fluctuating sales, peaking at 4,464.03 Cr in Mar'23 but declining to 4,223.67 Cr by Mar'25, alongside rising costs and challenges in profitability and cash flow. Despite growth in total assets from 1,811.84 Cr in Mar'20 to 3,449.99 Cr in Mar'25, the company has faced recent declines in operating profit and cash flow.

Answer:<BR>The historical performance of Galaxy Surfact shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Galaxy Surfact's net sales peaked at 4,464.03 Cr in Mar'23 but decreased to 4,223.67 Cr in Mar'25, reflecting a decline from the previous year. Total operating income followed a similar pattern, reaching its highest at 4,464.03 Cr in Mar'23 and then dropping to 4,223.67 Cr in Mar'25. The raw material cost increased significantly from 2,596.38 Cr in Mar'20 to 2,880.05 Cr in Mar'25, while total expenditure also rose from 2,227.47 Cr in Mar'20 to 3,739.44 Cr in Mar'25. Operating profit (PBDIT) saw a peak of 578.13 Cr in Mar'23 but fell to 510.04 Cr in Mar'25. Profit before tax was 380.45 Cr in Mar'25, slightly up from 375.47 Cr in Mar'24, while profit after tax was 304.91 Cr in Mar'25, showing a marginal increase from 301.47 Cr in Mar'24. The company's total assets grew from 1,811.84 Cr in Mar'20 to 3,449.99 Cr in Mar'25, indicating a strong asset base, while total liabilities also increased from 1,811.84 Cr in Mar'20 to 3,449.99 Cr in Mar'25. Cash flow from operating activities decreased from 572.00 Cr in Mar'23 to 420.00 Cr in Mar'25, and the net cash outflow was -27.00 Cr in Mar'25, indicating challenges in cash management. Overall, Galaxy Surfact has shown growth in assets and sales but faced profitability and cash flow challenges in recent years.

Is Galaxy Surfact. overvalued or undervalued?

As of November 14, 2025, Galaxy Surfactants is considered very expensive and overvalued with a PE ratio of 26.53, underperforming the Sensex with a year-to-date return of -15.2%, although its valuation is less extreme compared to peers like Solar Industries and Gujarat Fluoroch.

As of 14 November 2025, Galaxy Surfactants has moved from an expensive to a very expensive valuation grade. The company is currently considered overvalued based on its financial ratios. Notable ratios include a PE ratio of 26.53, an EV to EBITDA of 15.46, and a Price to Book Value of 3.00. <BR><BR>In comparison to peers, Galaxy Surfactants' PE ratio is significantly lower than Solar Industries at 95.17 and Gujarat Fluoroch at 57.32, both of which are also classified as very expensive. This suggests that while Galaxy Surfactants is overvalued, it is not as extreme as some of its peers. The company's recent stock performance has underperformed the Sensex, with a year-to-date return of -15.2% compared to the Sensex's 8.22%, reinforcing the notion of overvaluation.

Are Galaxy Surfactants Ltd latest results good or bad?

Galaxy Surfactants Ltd's latest results show strong revenue growth of 24.76% year-on-year, reaching ₹1,326.17 crores, but net profit declined by 21.51% to ₹66.49 crores, and operating margins fell sharply from 12.01% to 8.33%, indicating significant operational challenges. Overall, while revenue growth is positive, the decline in profitability raises concerns about the company's future performance.

Galaxy Surfactants Ltd's latest results present a mixed picture. On one hand, the company achieved a notable revenue growth of 24.76% year-on-year, reaching ₹1,326.17 crores, which is the highest quarterly revenue in its recent history. This indicates strong demand for its products.<BR><BR>However, the bottom-line performance is concerning. The net profit for Q2 FY26 was ₹66.49 crores, reflecting a significant decline of 21.51% compared to the same quarter last year. Additionally, the operating margin has contracted sharply from 12.01% in Q2 FY25 to just 8.33% in Q2 FY26, indicating that the company is facing substantial cost pressures that it has struggled to pass on to customers.<BR><BR>Overall, while the revenue growth is a positive sign, the decline in net profit and operating margins suggests that Galaxy Surfactants is currently grappling with operational challenges. This disconnect between revenue growth and profitability raises concerns about the company's ability to maintain its performance moving forward.

Should I buy, sell or hold Galaxy Surfactants Ltd?

Which are the latest news on Galaxy Surfact.?

When is the next results date for Galaxy Surfactants Ltd?

The next results date for Galaxy Surfactants Ltd is 14 May 2026.

The next results date for Galaxy Surfactants Ltd is scheduled for 14 May 2026.

Why is Galaxy Surfactants Ltd falling/rising?

As of 08-May, Galaxy Surfactants Ltd's stock price is falling, currently at 1,915.20, reflecting a decrease of 0.76%. Despite a recent positive return over the past week and month, the stock has underperformed year-to-date and over the past year, with declining investor interest and concerns about its financial health contributing to its downward trend.

As of 08-May, Galaxy Surfactants Ltd's stock price is falling, currently at 1,915.20, reflecting a decrease of 14.75 points or 0.76%. This decline comes after a trend reversal, as the stock had experienced four consecutive days of gains prior to this drop. The stock has underperformed its sector today, which has contributed to the negative movement in price.<BR><BR>In terms of performance metrics, while the stock has shown a positive return of 2.99% over the past week and 7.31% over the past month, it has a year-to-date decline of 5.91% and a one-year decline of 6.94%. This consistent underperformance against the benchmark, particularly over the last three years, indicates a troubling trend for investors. The stock has also seen a significant drop in investor participation, with delivery volume falling by 47.85% compared to the five-day average, suggesting decreased interest from traders.<BR><BR>Additionally, the company's financial health raises concerns. Despite a high return on equity (ROE) of 16.22%, the operating profit has grown at a negative annual rate of 0.33% over the last five years. The stock is trading at a premium compared to its peers, with a price-to-book value of 2.7, which is considered expensive given its recent performance. Overall, the combination of declining investor interest, poor long-term growth prospects, and high valuation relative to earnings contributes to the stock's current downward trajectory.